The International Society of Cell & Gene Therapy (ISCT) has responded to this issue by releasing a brief statement warning consumers to avoid these suspect therapies.*
- Given the fast spread of the COVID-19 pandemic, there is an urgent need for new therapy. Many pharmaceutical companies are now in the midst of developing treatments such as vaccines and diagnostics for this devastating disease.
- At the same time, however, there has also been an increase in promotion of unproven treatments against this infection, including stem cell-based therapy.
- ISCT experts warn that the spread of this information is “irresponsible,” particularly given the gravity of the current pandemic.
- People with pulmonary fibrosis (PF) and their family members should remember that they can be especially vulnerable to unproven and untested interventions.
- People with PF should follow only the recommendations of their physicians and allied medical professionals.
- ISCT’s Presidential Task Force offers resources to help guide consumers on the safe, genuine use of stem cell therapy for disease conditions.
ISCT is the world leader in development of cellular and gene-based therapeutics. Founded in 1992, the organization forms relationships between academic research institutions, industry partners, and regulatory agencies to drive innovation of cell- and gene-based therapies from the laboratory to the patient.
Read the original ISCT statement and visit the Pulmonary Fibrosis Foundation’s Stem Cell/Cell-Based Therapies Statement for more information.
*International Society for Cell & Gene Therapy. (2020, March 20). ISCT Releases Statement on Unproven Stem Cell Treatments for COVID-19 [News Release].